Skin responses to topical dehydroepiandrosterone: Implications in antiageing treatment?

British Journal of Dermatology

Volumn 163, Issue 5, 2010, Pages 968-976

  El Alfy, M ^a   Deloche, C ^b   Azzi, L ^a   Bernard, B A ^b   Bernerd, F ^b   Coutet, J ^b   Chaussade, V ^b   Martel, C ^a   Leclaire, J ^b   Labrie, F ^a  

^a LAVAL UNIVERSITY   (Canada)

^b Centre Charles Zviak   (France)

Author keywords

Androgen receptor; DHEA; Menopause; Skin

Indexed keywords

ANDROGEN RECEPTOR; CHAPERONE; HEAT SHOCK PROTEIN 47; MESSENGER RNA; PLACEBO; PRASTERONE; PROCOLLAGEN; PROCOLLAGEN 1; PROCOLLAGEN 3; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ARM; ARTICLE; BIOPSY; BIOSYNTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DERMIS; DRUG RESPONSE; EPIDERMIS; FACE; FEMALE; HAND; HUMAN; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; THIGH; THORAX;

ADMINISTRATION, TOPICAL; AGED; BIOPSY; DEHYDROEPIANDROSTERONE; DERMATOLOGIC AGENTS; DERMIS; EPIDERMIS; FEMALE; HSP47 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; POSTMENOPAUSE; PROCOLLAGEN; PROSPECTIVE STUDIES; RECEPTORS, ANDROGEN; RNA, MESSENGER; SKIN AGING;

EID: 78249266620     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09972.x     Document Type: Article

References (49)

1. Zouboulis CC, Boschnakow A,. Chronological ageing and photoageing of the human sebaceous gland. Clin Exp Dermatol 2001; 26: 600 -7.
2. Labrie F, Bélanger A, Bélanger P, et al. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 2006; 99: 182 -8.
3. Labrie F,. DHEA after menopause -sole source of sex steroids and potential sex steroid deficiency treatment. Menopause Manag 2010; 19: 14 -24.
4. Jemec GB, Serup J,. Short-term effects of topical 17 beta-oestradiol on human post-menopausal skin. Maturitas 1989; 11: 229 -34.
5. Punnonen R, Vaajalahti P, Teisala K,. Local oestriol treatment improves the structure of elastic fibers in the skin of postmenopausal women. Ann Chir Gynaecol Suppl 1987; 202: 39 -41.
6. Bélanger A, Candas B, Dupont A, et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40-to 80-year-old men. J Clin Endocrinol Metab 1994; 79: 1086 -90.
7. Labrie F, Bélanger A, Cusan L, et al. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82: 2396 -402.
8. Labrie F, Luu-The V, Bélanger A, et al. Is DHEA a hormone? Starling review. J Endocrinol 2005; 187: 169 -96.
9. Orentreich N, Brind JL, Rizer RL, Vogelman JH,. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59: 551 -5.
10. Tchernof A, Després JP, Dupont A, et al. Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Diabetes Care 1995; 18: 292 -9.
11. MacEwen EG, Kurzman ID,. Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA). J Nutr 1991; 121: S51 -5.
12. Coleman DL, Schwizer RW, Leiter EH,. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. Diabetes 1984; 33: 26 -32.
13. Nestler JE, Clore JN, Blackard WG,. Dehydroepiandrosterone: the missing link between hyperinsulinemia and atherosclerosis? FASEB J 1992; 6: 3073 -5.
14. Labrie F, Archer D, Bouchard C, et al. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause 2009; 16: 907 -22.
15. Labrie F, Archer D, Bouchard C, et al. Effect on intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 2009; 16: 923 -31.
16. Labrie F, Archer D, Bouchard C, et al. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 2009; 16: 897 -906.
17. Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA 2000; 97: 4279 -84.
18. Diamond P, Cusan L, Gomez JL, et al. Metabolic effects of 12-month percutaneous DHEA replacement therapy in postmenopausal women. J Endocrinol 1996; 150: S43 -50.
19. Labrie F, Diamond P, Cusan L, et al. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997; 82: 3498 -505.
20. Morales AJ, Nolan JJ, Nelson JC, Yen SS,. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360 -7.
21. Labrie F,. Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy. Nat Clin Pract Endocrinol Metab 2007; 3: 584 -93.
22. Azzi L, El-Alfy M, Martel C, Labrie F,. Gender differences in mouse skin morphology and specific effects of sex steroids and dehydroepiandrosterone. J Invest Dermatol 2005; 124: 22 -7.
23. Sourla A, Richard V, Labrie F, Labrie C,. Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin. J Endocrinol 2000; 166: 455 -62.
24. Mills SJ, Ashworth JJ, Gilliver SC, et al. The sex steroid precursor DHEA accelerates cutaneous wound healing via the estrogen receptors. J Invest Dermatol 2005; 125: 1053 -62.
25. Labrie F,. Intracrinology. Mol Cell Endocrinol 1991; 78: C113 -18.
26. Labrie F, Luu-The V, Labrie C, et al. Intracrinology and the skin. Horm Res 2000; 54: 218 -29.
27. Gingras S, Turgeon C, Brochu N, et al. Characterization and modulation of sex steroid metabolizing activity in normal human keratinocytes in primary culture and HaCaT cells. J Steroid Biochem Mol Biol 2003; 87: 167 -79.
28. Labrie F, Bélanger A, Bélanger P, et al. Metabolism of DHEA in postmenopausal women following percutaneous administration. J Steroid Biochem Mol Biol 2007; 103: 178 -88.
29. Shin MH, Rhie GE, Park CH, et al. Modulation of collagen metabolism by the topical application of dehydroepiandrosterone to human skin. J Invest Dermatol 2005; 124: 315 -23.
30. Calvo E, Luu-The V, Morissette J, et al. Pangenomic changes induced by DHEA in the skin of postmenopausal women. J Steroid Biochem Mol Biol 2008; 112: 186 -93.
31. Tacha DE, Chen T,. Modified antigen retrieval procedure: calibration technique for microwave ovens. J Histotechnol 1997; 17: 365 -6.
32. Thornton MJ, Taylor AH, Mulligan K, et al. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol 2003; 12: 181 -90.
33. Dafforn TR, Della M, Miller AD,. The molecular interactions of heat shock protein 47 (Hsp47) and their implications for collagen biosynthesis. J Biol Chem 2001; 276: 49310 -19.
34. Choudhry R, Hodgins MB, Van der Kwast TK, et al. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992; 133: 467 -75.
35. Hibberts NA, Howell AE, Randall VA,. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998; 156: 59 -65.
36. Mowszowicz I, Riahi M, Wright F,. Androgen receptors in human skin cytosol. J Clin Endocrinol Metab 1981; 52: 338 -44.
37. Dumont M, Luu-The V, Dupont E, et al. Characterization, expression and immunohistochemical localization of 3beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human skin. J Invest Dermatol 1992; 99: 415 -21.
38. Hay JB, Hodgins MB,. Distribution of androgen metabolizing enzymes in isolated tissues of human forehead and axillary skin. J Endocrinol 1978; 79: 29 -39.
39. Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138: 1462 -70.
40. Moragas A, Garcia-Bonafe M, Sans M, et al. Image analysis of dermal collagen changes during skin aging. Anal Quant Cytol Histol 1998; 20: 493 -9.
41. Brincat M, Versi E, Moniz CF, et al. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987; 70: 123 -7.
42. Affinito P, Palomba S, Sorrentino C, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas 1999; 33: 239 -47.
43. Brincat M, Moniz CJ, Studd JW, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985; 92: 256 -9.
44. Shuster S, Black MM, McVitie E,. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 1975; 93: 639 -43.
45. Liu X, Wu H, Byrne M, et al. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci USA 1997; 94: 1852 -6.
46. Stevenson K, Kucich U, Whitbeck C, et al. Functional changes in bladder tissue from type III collagen-deficient mice. Mol Cell Biochem 2006; 283: 107 -14.
47. Johnson BD, Page RC, Narayanan AS, Pieters HP,. Effects of donor age on protein and collagen synthesis in vitro by human diploid fibroblasts. Lab Invest 1986; 55: 490 -6.
48. Lee KS, Oh KY, Kim BC,. Effects of dehydroepiandrosterone on collagen and collagenase gene expression by skin fibroblasts in culture. J Dermatol Sci 2000; 23: 103 -10.
49. Jo H, Park JS, Kim EM, et al. The in vitro effects of dehydroepiandrosterone on human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2003; 11: 585 -94.